言語を選択

Vitronectin

Vitronectin 詳細

英語名	Vitronectin	市販薬剤の数	0
治験薬の数	0	ターゲットの別称	Vitronectin，V75，VN，Serum-spreading factor，Vitronectin (Serum Spreading Factor， Somatomedin B， Complement S-Protein)，Somatomedin B，Epibolin，Serum Spreading Factor，VNT，S-protein，Complement S-Protein，Protein S
研究＆開発段階	Preclinical

英語名	Vitronectin
ターゲットの別称	Vitronectin，V75，VN，Serum-spreading factor，Vitronectin (Serum Spreading Factor， Somatomedin B， Complement S-Protein)，Somatomedin B，Epibolin，Serum Spreading Factor，VNT，S-protein，Complement S-Protein，Protein S
市販薬剤の数	0
治験薬の数	0
研究＆開発段階	Preclinical

Vitronectin 製品リスト

属性
Protein (4)Kits (1)
製品ライブラリ
オンライン (5)
種
Human (5)
タグ
Tag Free (4)- (1)
マーカー
Unconjugated (4)- (1)

製品番号	種	発現システム	製品説明
GMP-VINH19	Human	E. coli	GMP Human Truncated Vitronectin / VTN-N Protein
RES-A103	Human	-	resDetect™ Vitronectin ELISA Kit (Residue Testing)
VIN-H5117	Human	E. coli	Human Truncated Vitronectin / VTN-N Protein, premium grade
VIN-H5118	Human	E. coli	Human Truncated Vitronectin / VTN-N Protein, Research Grade
VIN-H5214	Human	HEK293	Human Vitronectin / VTN Protein, Tag Free, low endotoxin

総数量5

Vitronectinバックグランド

Vitronectin is also known as S-protein, VN, VTN, V75. Vitronectin, a multifunctional glycoprotein, is involved in coagulation, inhibition of the formation of the membrane attack complex (MAC), cell adhesion and migration, wound healing, and tissue remodeling. The primary cellular source of vitronectin is hepatocytes. Blocking of Hic(a member of the pneumococcal surface protein C (PspC) family) by specific antiserum or genetic deletion significantly reduced pneumococcal binding to soluble and immobilised vitronectin and to Factor H, respectively. In addition, Vitronectin interact with glycosaminoglycans and proteoglycans. Is recognized by certain members of the integrin family and serves as a cell-to-substrate adhesion molecule. Inhibitor of the membrane-damaging effect of the terminal cytolytic complement pathway.